دورية أكاديمية

‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies

التفاصيل البيبلوغرافية
العنوان: ‘Real-World’ Impact of Tixagevimab/Cilgavimab (Evusheld) on COVID-19 Outcomes in Patients Undergoing Cellular Therapies
المؤلفون: Sannareddy, Aishwarya, Reves, Heather, Narasimhan, Madhusudhanan, Jaleta, Kefyalew, Anderson, Julia Marie, Patel, Hetalkumari, Anderson, Larry D., Afrough, Aimaz, Chung, Stephen, Collins, Robert H., Kaur, Gurbakhash, Kumar, Kiran A, Madanat, Yazan F., Vusirikala, Madhuri, Awan, Farrukh T, Muthukumar, Alagar R, Geethakumari, Praveen Ramakrishnan
المصدر: Transplantation and Cellular Therapy ; volume 29, issue 2, page S330 ; ISSN 2666-6367
بيانات النشر: Elsevier BV
سنة النشر: 2023
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Transplantation, Cell Biology, Hematology, Molecular Medicine, Immunology and Allergy
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/s2666-6367(23)00505-5
الإتاحة: https://doi.org/10.1016/s2666-6367Test(23)00505-5
https://api.elsevier.com/content/article/PII:S2666636723005055?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2666636723005055?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; http://creativecommons.org/licenses/by-nc-nd/4.0Test/
رقم الانضمام: edsbas.2900728D
قاعدة البيانات: BASE